oxazoles has been researched along with atrial natriuretic factor in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DeLuca, N; Lorino, G; Rosiello, G; Rubattu, S; Sarno, D; Trimarco, B; Volpe, M | 1 |
| Argenziano, L; De Luca, N; Iovino, G; Morisco, C; Russo, R; Sarno, D; Trimarco, B; Volpe, M | 1 |
| Jimi, N; Minami, K; Nakashima, Y; Segawa, K; Shigematsu, A | 1 |
| González-Santiago, L; Griera, M; López-Ongil, S; Molpeceres, J; Rodríguez-Puyol, D; Rodríguez-Puyol, M | 1 |
| Ellis-Davies, GC; Levitan, ES; Lu, X; Ng, YK; Watkins, SC | 1 |
| Cao, LH; Yang, XL; Yu, YC | 1 |
| Gao, J; Han, QD; Lan, XM; Luo, DL; Wang, G; Wei, S; Xiao, RP | 1 |
2 trial(s) available for oxazoles and atrial natriuretic factor
| Article | Year |
|---|---|
Effects of one-year treatment with rilmenidine on systemic hypertension-induced left ventricular hypertrophy in hypertensive patients.
Topics: Antihypertensive Agents; Atrial Natriuretic Factor; Echocardiography; Female; Forearm; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Oxazoles; Renin; Rilmenidine; Vascular Resistance | 1994 |
Rilmenidine in patients with left ventricular hypertrophy: beyond the reduction of left ventricular mass.
Topics: Antihypertensive Agents; Atrial Natriuretic Factor; Drug Administration Schedule; Electrolytes; Female; Heart Ventricles; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Oxazoles; Renin; Rilmenidine | 1995 |
5 other study(ies) available for oxazoles and atrial natriuretic factor
| Article | Year |
|---|---|
C-type natriuretic peptide inhibits rat mesangial cell proliferation by a phosphorylation-dependent mechanism.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cell Count; Cell Division; Cells, Cultured; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP; Enzyme Inhibitors; Glomerular Mesangium; Interleukin-1; Interleukin-6; Marine Toxins; Natriuretic Peptide, C-Type; Oxazoles; Phosphoprotein Phosphatases; Phosphorylation; Platelet-Derived Growth Factor; Protein Kinase C; Proteins; Rats; Thymidine | 1998 |
Mechanisms involved in the relaxation of bovine aortic endothelial cells.
Topics: Animals; Aorta; Atrial Natriuretic Factor; Calcium; Cattle; Cell Survival; Cells, Cultured; Cyclic GMP-Dependent Protein Kinases; Dibutyryl Cyclic GMP; Drug Antagonism; Endothelium, Vascular; Enzyme Inhibitors; Hydrogen Peroxide; Marine Toxins; Myosin Light Chains; Natriuretic Peptide, C-Type; Nitroprusside; Oxazoles; Phosphorylation; Vasodilation | 2001 |
Nerve growth factor-induced differentiation changes the cellular organization of regulated Peptide release by PC12 cells.
Topics: Actin Cytoskeleton; Actins; Animals; Atrial Natriuretic Factor; Barium; Calcium; Cell Differentiation; Chromaffin Cells; Egtazic Acid; Enzyme Inhibitors; Green Fluorescent Proteins; Growth Cones; Ionophores; Luminescent Proteins; Marine Toxins; Microscopy, Confocal; Nerve Growth Factor; Oxazoles; PC12 Cells; Peptides; Photolysis; Protein Precursors; Rats; Recombinant Fusion Proteins; Secretory Vesicles | 2002 |
Modulation by brain natriuretic peptide of GABA receptors on rat retinal ON-type bipolar cells.
Topics: Animals; Atrial Natriuretic Factor; Caffeine; Calcium; Calcium Channels; Calcium Signaling; Calcium-Transporting ATPases; Calmodulin; Carbazoles; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; GABA-A Receptor Antagonists; gamma-Aminobutyric Acid; Guanylate Cyclase; Heparin; Imidazoles; Indoles; Inositol 1,4,5-Trisphosphate Receptors; Macrocyclic Compounds; Male; Membrane Potentials; Natriuretic Peptide, Brain; Oxazoles; Patch-Clamp Techniques; Peptide Fragments; Peptides, Cyclic; Polysaccharides; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Atrial Natriuretic Factor; Receptors, Cytoplasmic and Nuclear; Receptors, GABA; Receptors, GABA-A; Retinal Bipolar Cells; Ruthenium Red; Ryanodine; Ryanodine Receptor Calcium Release Channel; Thapsigargin | 2006 |
Role of inositol 1,4,5-trisphosphate receptors in alpha1-adrenergic receptor-induced cardiomyocyte hypertrophy.
Topics: Adrenergic alpha-1 Receptor Agonists; Animals; Animals, Newborn; Atrial Natriuretic Factor; Boron Compounds; Calcium; Calcium Signaling; Cells, Cultured; Heart Ventricles; Hypertrophy; Inositol 1,4,5-Trisphosphate Receptors; Leucine; Macrocyclic Compounds; Myocytes, Cardiac; Oxazoles; Phenylephrine; Rats; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction | 2006 |